Potential causes include pre-existing vascular ED that was present before tirzepatide but was attributed to the medication, medication interactions with drugs known to cause ED (SSRIs, beta-blockers, spironolactone, finasteride), severe nutritional deficiencies from inadequate intake, or undiagnosed conditions like depression or hypogonadism unrelated to obesity
Weight Loss Peptides: Until Goal Achieved Semaglutide & Tirzepatide : These are typically run as long as necessary to reach a target weight or body fat percentage
Cell 120 (3), 421433
it is the possibility of a more flexible treatment pathway, provided the patient remains supported and clinically monitored
SEMA reversed key features of obesity-induced cardiometabolic heart disease, including ectopic lipid accumulation, CMD, and systolic and diastolic strain impairments, independently of dietary intake